Advanced Triple-Negative Breast Cancer
14 clinical trials · Condition
◉ Watch Advanced Triple-Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer (NCT05019690) | Fujian Cancer Hospital | 2021-10-01 |
| A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies (NCT04927884) | ImmunityBio, Inc. | 2021-09-08 |
| A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors (NCT03861403) | Leap Therapeutics, Inc. | 2019-05-20 |
| Vinorelbine Plus Apatinib Versus Vinorelbine in Advanced Triple-Negative Breast Cancer (NCT03254654) | Fudan University | 2017-08-16 |
| A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients (NCT02661100) | Case Comprehensive Cancer Center | 2017-01-01 |
| A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer (NCT02038699) | Jazz Pharmaceuticals | 2014-01-01 |
Track Advanced Triple-Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.